摘要
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic. The interplay between innate and adaptive immune responses plays a crucial role in managing COVID-19. Cell therapy has recently emerged as a promising strategy to modulate the immune system, offering immense potential for the treatment of COVID-19 due to its customizability and regenerative capabilities. This review provides an overview of the various subsets of immune cell subsets implicated in the pathogenesis of COVID-19 and a comprehensive summary of the current status of immune cell therapy in COVID-19 treatment.
学科与关键词
关键词
SARS-CoV-2COVID-19cell therapyimmunotherapy
- Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDSXu, Zhiheng; Huang, Yongbo; Zhou, Jianmeng; Deng, Xiumei; He, Weiqun; Liu, Xiaoqing; Li, Yimin; Zhong, Nanshan*; Sang, Ling*Frontiers in Immunology, 2021, 12: 738697.被引 13
- The immunology and immunotherapy for COVID-19Liu, Yixin; Zhou, Xinsheng; Liu, Xuan*; Jiang, Xiaotao*EXPERT REVIEWS IN MOLECULAR MEDICINE, 2021, 23: e24.被引 3
- COVID-19: immunopathogenesis and Immunotherapeutics.Yang, Li; Liu, Shasha; Liu, Jinyan; Zhang, Zhixin; Wan, Xiaochun; Huang, Bo; Chen, Youhai; Zhang, Yi*Signal Transduct Target Ther, 2020, 5(1): 128.
